Paul Titley at Aesica Pharmaceuticals and Peter York at Crystec Pharma, discuss the design, development and manufacture of modern medicines pose numerous scientific and technical challenges to drug delivery and pharmaceutical companies. Increasingly, companies are finding that approaches which have traditionally been used to overcome these problems and in-house experience/expertise available are no longer appropriate or sufficiently versatile to solve many of the emerging issues.
https://international-pharma.com/wp-content/uploads/2013/10/Partnering-to-drive.pdf